Robert L. Ferrara

PHIO

DIRECTOR · PHIO PHARMACEUTICALS CORP. · CIK 0001792987

FILING MIX · LIFETIME100%/0%

BUYS

SELLS

TOTAL VALUE

$21.8K

COMPANIES

ACTIVE SINCE

Mar 2021

HOLDINGS NOW

38,766

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

6 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Robert L. Ferrara, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	6	+16.67%	-2.85%	-0.21%	-2.64%	-3.58%	—
14d	6	+33.33%	-2.00%	-0.36%	-1.64%	-1.80%	—
30d	6	+16.67%	-1.80%	+0.51%	-2.31%	-6.48%	—
60d	6	+50.00%	+5.66%	+4.13%	+1.53%	+6.73%	—
90d	6	+50.00%	-5.05%	+4.45%	-9.50%	-7.54%	—
180d	6	+0.00%	-38.18%	+9.99%	-48.17%	-47.09%	—
1y	6	+0.00%	-66.43%	+19.75%	-86.19%	-87.98%	—
2y	6(2 pending)	+0.00%	-90.65%	+38.62%	-129.27%	-139.10%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

PHIO · 38,766 shares · as of Sep 11, 2025

Trading cadence · quarterly flow

BUY ● SELL ●

2021

2022

2023

2024

2025

FLOW · 12 buys / 0 sellsCOVERAGE · 19 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	23,000	—	—	38,666	Sep 11, 2025	Sep 15, 2025 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	23,100	—	—	38,766	Sep 11, 2025	Sep 15, 2025 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	2,500	$2.42	$6.0K	15,666	Jun 10, 2025	Jun 11, 2025 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	2,500	$1.82	$4.5K	13,166	May 20, 2025	May 21, 2025 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	10,000	—	—	10,000	Sep 11, 2024	Sep 12, 2024 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	2,000	$3.10	$6.2K	6,000	Jun 14, 2023	Jun 15, 2023 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	1,500	—	—	4,000	Feb 17, 2023	Feb 22, 2023 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	5,000	$0.41	$2.0K	30,000	Dec 2, 2022	Dec 5, 2022 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	2,000	$0.41	$820	25,000	Nov 23, 2022	Nov 28, 2022 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	10,000	—	—	23,000	Feb 15, 2022	Feb 16, 2022 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASE	682	$3.15	$2.1K	13,000	Mar 3, 2021	Mar 3, 2021 ↗	View →
PHIO PHIO PHARMACEUTICALS CORP.	PURCHASEGRANT Stock grant	10,000	—	—	12,318	Mar 1, 2021	Mar 3, 2021 ↗	View →

Other insiders · PHIO

Loading peer insiders…

About this filer

CIK 0001792987

ROLE

Director

PRIMARY

PHIO

COMPANIES

ACTIVE SINCE

Mar 2021

MARKETPEEL · /INSIDER/0001792987DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Robert L. Ferrara

The morning brief, before the bell.